89 related articles for article (PubMed ID: 22609326)
1. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine.
Hoeltzenbein M; Weber-Schoendorfer C; Borisch C; Allignol A; Meister R; Schaefer C
Reprod Toxicol; 2012 Nov; 34(3):364-9. PubMed ID: 22609326
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
Teruel C; López-San Román A; Bermejo F; Taxonera C; Pérez-Calle JL; Gisbert JP; Martín-Arranz M; Ponferrada A; Van Domselaar M; Algaba A; Estellés J; López-Serrano P; Linares PM; Muriel A
Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
[TBL] [Abstract][Full Text] [Related]
3. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
4. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
5. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.
Rajapakse RO; Korelitz BI; Zlatanic J; Baiocco PJ; Gleim GW
Am J Gastroenterol; 2000 Mar; 95(3):684-8. PubMed ID: 10710057
[TBL] [Abstract][Full Text] [Related]
6. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
[TBL] [Abstract][Full Text] [Related]
7. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
[TBL] [Abstract][Full Text] [Related]
8. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
Francella A; Dyan A; Bodian C; Rubin P; Chapman M; Present DH
Gastroenterology; 2003 Jan; 124(1):9-17. PubMed ID: 12512024
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
10. Early pregnancy azathioprine use and pregnancy outcomes.
Cleary BJ; Källén B
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):647-54. PubMed ID: 19343728
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
Fernández Liguori N; Klajn D; Acion L; Cáceres F; Calle A; Carrá A; Cristiano E; Deri N; Garcea O; Jaureguiberry A; Onaha P; Patrucco L; Riccio P; Rotta Escalante R; Saladino Ml; Sinay V; Tarulla A; Villa A
Mult Scler; 2009 May; 15(5):555-62. PubMed ID: 19299437
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes.
Terrabuio DR; Abrantes-Lemos CP; Carrilho FJ; Cançado EL
J Clin Gastroenterol; 2009 Apr; 43(4):350-6. PubMed ID: 19077726
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
15. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome post renal transplantation.
Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine.
Gardiner SJ; Begg EJ; Barclay ML; Kirkpatrick CM
Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):293-312. PubMed ID: 11212460
[No Abstract] [Full Text] [Related]
20. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
